These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 430478

  • 1. Antianaphylactic agents. 1. 2-(Acylamino)oxazoles.
    Ross WJ, Harrison RG, Jolley MR, Neville MC, Todd A, Verge JP, Dawson W, Sweatman WJ.
    J Med Chem; 1979 Apr; 22(4):412-7. PubMed ID: 430478
    [Abstract] [Full Text] [Related]

  • 2. The pharmacology of isamoxole [2-methyl-n-butyl-n(4-methyloxazol-2-yl) propanamide] LRCL 3950, a new anti-allergic compound.
    Dawson W, Sweatman WJ.
    Br J Pharmacol; 1980 Apr; 71(2):387-98. PubMed ID: 6781575
    [Abstract] [Full Text] [Related]

  • 3. Antianaphylactic benzophenones and related compounds.
    Evans D, Cracknell ME, Saunders JC, Smith CE, Williamson WR, Dawson W, Sweatman WJ.
    J Med Chem; 1987 Aug; 30(8):1321-7. PubMed ID: 3612683
    [Abstract] [Full Text] [Related]

  • 4. The influence of a new corticosteroid, budesonide, on anaphylactic bronchoconstriction and SRS-A release in the guinea pig.
    Forsberg K, Sörenby L.
    Agents Actions; 1981 Jul; 11(4):391-5. PubMed ID: 6169265
    [Abstract] [Full Text] [Related]

  • 5. Effect of butyl 3-(1H-tetrazol-5-Yl) oxanilate (MTB) on immunological or non-immunological histamine and SRS(-A) release from guinea-pig, monkey and human lung tissue.
    Hashimoto T, Kohno SW, Ohata K, Yanagihara Y, Shida T.
    Jpn J Pharmacol; 1987 Aug; 44(4):447-53. PubMed ID: 2446036
    [Abstract] [Full Text] [Related]

  • 6. Immunopharmacological studies on mydocalm and related compounds as an antagonist of slow reacting substance of anaphylaxis (SRS-A).
    Nagai H, Matsuura N, Sato N, Koda A, Kohno S.
    J Pharmacobiodyn; 1983 Nov; 6(11):874-80. PubMed ID: 6199492
    [Abstract] [Full Text] [Related]

  • 7. Anti-anaphylactic activity of the novel selective histamine H1 receptor antagonist mizolastine in the rodent.
    Levrier J, Duval D, Prouteau M, Voltz C, Berry CN, Lloyd KG, Scatton B.
    Arzneimittelforschung; 1995 May; 45(5):559-68. PubMed ID: 7541995
    [Abstract] [Full Text] [Related]

  • 8. Effect of clenbuterol, a new beta 2 selective adrenoceptor stimulant, on the release of histamine and SRS-A from passively sensitized guinea-pig chopped lungs.
    Yamazaki N, Hosoki R, Takayanagi I.
    Gen Pharmacol; 1984 May; 15(4):345-8. PubMed ID: 6208080
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of immediate hypersensitivity reactions in laboratory animals by a phenanthroline salt (ICI 74,917).
    Evans DP, Thomson DS.
    Br J Pharmacol; 1975 Mar; 53(3):409-18. PubMed ID: 48393
    [Abstract] [Full Text] [Related]

  • 10. Effects of the new antiallergic drug 11-oxo-11H-pyrido[2,1-b] quinazoline-2-carboxylic acid on type I allergic reactions.
    Kohno SW, Murata T, Kinoshita T, Ohata K.
    Arzneimittelforschung; 1986 Nov; 36(11):1619-27. PubMed ID: 2434110
    [Abstract] [Full Text] [Related]

  • 11. KC-404: a potential anti-allergic agent with antagonistic action against slow reacting substance of anaphylaxis.
    Nishino K, Ohkubo H, Ohashi M, Hara S, Kito J, Irikura T.
    Jpn J Pharmacol; 1983 Apr; 33(2):267-78. PubMed ID: 6193303
    [Abstract] [Full Text] [Related]

  • 12. Smooth muscle contraction and release of histamine and slow-reacting substance of anaphylaxis in pulmonary tissues isolated from guinea pigs passively sensitized with IgG1 or IgE antibodies.
    Undem BJ, Buckner CK, Harley P, Graziano FM.
    Am Rev Respir Dis; 1985 Feb; 131(2):260-6. PubMed ID: 2578761
    [Abstract] [Full Text] [Related]

  • 13. A comparison of the anti-anaphylactic activities of salbutamol and disodium cromoglycate in the rat, the rat mast cell and in human lung tissue.
    Butchers PR, Fullarton JR, Skidmore IF, Thompson LE, Vardey CJ, Wheeldon A.
    Br J Pharmacol; 1979 Sep; 67(1):23-32. PubMed ID: 115530
    [Abstract] [Full Text] [Related]

  • 14. Ro 22-3747: a new antiallergic agent for the treatment of immediate hypersensitivity diseases.
    Welton AF, Hope WC, O'Donnell M, Baruth H, Crowley HJ, Miller DA, Yaremko B.
    J Pharmacol Exp Ther; 1984 Jan; 228(1):57-64. PubMed ID: 6198511
    [Abstract] [Full Text] [Related]

  • 15. Immunopharmacological studies of sodium copper chlorphyllin (SCC).
    Nagai H, Nishiyori T, Daikoku M, Koda A.
    Jpn J Pharmacol; 1983 Aug; 33(4):819-28. PubMed ID: 6195383
    [Abstract] [Full Text] [Related]

  • 16. New inhibitor of reagin-mediated anaphylaxis.
    Broughton BJ, Chaplen P, Knowles P, Lunt E, Pain DL, Wooldridge KR, Ford R, Marshall S, Walker JL, Maxwell DR.
    Nature; 1974 Oct 18; 251(5476):650-2. PubMed ID: 4138541
    [No Abstract] [Full Text] [Related]

  • 17. Non-immunological release of slow-reacting substance from guinea-pig lungs.
    Piper PJ, Seale JP.
    Br J Pharmacol; 1979 Sep 18; 67(1):67-72. PubMed ID: 91403
    [Abstract] [Full Text] [Related]

  • 18. The effect of lipoxygenase inhibitors and diethylcarbamazine on the immunological release of slow reacting substance of anaphylaxis (SRS-A) from guinea-pig chopped lung.
    Piper PJ, Temple DM.
    J Pharm Pharmacol; 1981 Jun 18; 33(6):384-6. PubMed ID: 6115013
    [No Abstract] [Full Text] [Related]

  • 19. Inhibition of passive lung anaphylaxis in the rat by AY-25,674.
    Greenberg R, Martel RR, Smorong K.
    Can J Physiol Pharmacol; 1979 Jan 18; 57(1):48-52. PubMed ID: 106941
    [Abstract] [Full Text] [Related]

  • 20. Effects of sodium cromoglycate analogues on the immunological release of slow reacting substance of anaphylaxis and histamine from human and guinea-pig lung in vitro.
    Armour CL, Hughes JM, Seale JP, Temple DM.
    J Pharm Pharmacol; 1982 Jun 18; 34(6):401-2. PubMed ID: 6178815
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.